SPIL1033

· Sun Pharmaceutical Industries Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPIL1033, covering 2019-11-01 to 2019-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus [Phase 3]